Niki BioSolutions, Inc. Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
Niki BioSolutions, Inc. (NIKI) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of $712.92 thousand for the 6-month period ending 2021-06-30, per its 6-K filed 2021-09-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2021-09-15
- 2021-06-30: Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 6 month $712.92K.
- 2020-06-30: Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 6 month $584.90K.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 6 month |
|---|---|
| 2021-06-30 | $712.92K 6-K · filed 2021-09-15 |
| 2020-06-30 | $584.90K 6-K · filed 2021-09-15 |